Monsanto (NYSE:MON) Stock Upgrade
In a very recent research note shared with investors and clients on 1 December, Atlantic Equities raised shares of Monsanto (NYSE:MON) to a solid “Overweight” rating from their previous “Neutral” rating.
From a total of 19 analysts covering Monsanto Company (NYSE:MON) stock, 13 rate it a ”Buy”, 2 a “Sell”, and 9 a ”Hold”. This means that 54% of the ratings are positive. The highest target price is $125 while the lowest target price is $84. The mean of all analyst targets is $106.89 with a 15.88% above today’s ($96.4) stock price. Monsanto Company was the topic of 17 analyst reports since August 25, 2015 according to the firm StockzIntelligence Inc. Argus Research maintained shares on October 9 with “Buy” rating. Bernstein initiated shares with “Underperform” rating and $85 target share price in a report from a September 11. UBS maintained MON stock in a recent report from October 8 with “Buy” rating. Morgan Stanley reinitiated the rating on August 27. Morgan Stanley has a “Overweight” rating and a $120 price target on shares. Finally, Goldman Sachs reinitiated the stock with “Neutral” rating in a report issued on a September 23.
Approximately 1.76M shares of stock traded hands. Monsanto Company (NYSE:MON) has declined 17.25% since April 28, 2015 and is downtrending. It has underperformed by 15.63% the S&P500.
Analysts await Monsanto Company (NYSE:MON) to reports earnings on January, 6. They expect $0.08 EPS, down 82.98% or $0.39 from last year’s $0.47 per share. MON’s profit will be $35.29 million for 301.25 P/E if the $0.08 EPS becomes reality. After $-0.19 actual EPS reported by Monsanto Company for the previous quarter, Wall Street now forecasts -142.11% EPS growth.
Monsanto Company is a provider of agricultural products for farmers. The company has a market cap of $42.52 billion. The Company’s seeds, biotechnology trait products, and herbicides provide farmers with solutions that improve productivity, reduce the costs of farming, and produce better foods for clients and better feed for animals. It has 20.53 P/E ratio. It manages business in two divisions: Seeds and Genomics, and Agricultural Productivity.
According to Zacks Investment Research, “Monsanto is a leading global provider of technology-based solutions and agricultural products for growers and downstream customers, such as grain processors and consumers, in the agricultural markets. The combination of its herbicides, seeds and related genetic trait products provides growers with integrated solutions to more efficiently and cost effectively produce crops at higher yields, while controlling weeds, insects and diseases. Its base business, led by Roundup and coupled with the latest tools in biotechnology, genomics and molecular breeding.” Get a free copy of the Zacks research report on Monsanto Company (MON)